Kevin Famuyiro is a Senior Content Strategist at LA Times Studios, curating content by working closely with doctors, scientists and healthcare experts as well as sourcing scholarly-reviewed medical and science journals.
Latest From This Author
Fourth edition of Saudi Arabia’s flagship summit aims to accelerate biomanufacturing, precision medicine, and $34.6 billion non-oil GDP targets under royal patronage.
A Cedars-Sinai analysis of 354,957 adults links coffee intake to less liver fat, lower scarring, and a 47 percent lower risk of liver cancer.
California mandates dedicated pharmacy staffing and expands technician vaccine roles, reshaping retail immunization workflows.
High-resolution retinal imaging shows decreased foveal cone density in children receiving red-light myopia therapy for over one year.
Two infant botulism outbreaks traced to the same milk supplier pushed the FDA to tell formula makers their ingredient checks are not enough.
Assembly Bill 1883 would bar AI-powered tools from reading workers’ neural data or emotional states, with penalties up to $500 per violation.
Explore clinical evidence for peptide therapy, from GLP-1s to retatrutide. Dr. Amir Kalantar breaks down the science, safety, and future of metabolic medicine.
An FDA advisory committee recommended six peptides for compounding, despite career staff citing thin human trial data and safety risks.
A JAMA trial shows that sequential EHR prompts based on behavioral science increase medication deprescribing in older adults by 40%
Impaired glucose signaling in the brain contributes to depression. Clinical trials demonstrate that reversing insulin resistance improves mood.